NEW YORK (GenomeWeb News) - Osmetech has named Daryl Faulkner to be non-executive chairman. The company’s current chairman, Gordon Hall, will step down but will remain on the board as a non-executive director.
 
Faulkner recently was president and CEO of Digene, and he was a senior VP and GM for strategic business and international operations at Invitrogen.
 
Osmetech also said that Bruce Huebner has retired from the company and has left his position as a director.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.